Postdoctoral Fellows
Vasiliki Liaki, PhD
lvasiliki@cnio.es
vasiliki-liaki
Dr. Vasiliki Liaki specializes in molecular therapeutics of pancreatic ductal adenocarcinoma. She conducts bioinformatic analyses to translate big data to targeted therapies. She also performs preclinical studies with mouse models and human-derived samples using genetic and pharmacological approaches. She has recently validated the efficacy of a new therapeutic strategy based on the combined inhibition of EGFR, RAF1 and STAT3. Currently, she is investigating the molecular mechanisms of advanced and metastatic pancreatic cancer, as these highly aggressive tumors have nowadays no treatment options.
Juan Carlos López-Gil, PhD
jlopezg@cnio.es
lopez-gil-juancarlos
Dr. Juan Carlos López Gil research focuses on understanding how inflammation and genetic alterations drive the origin and evolution of pancreatic cancer stem cells (CSCs), and how these factors influence tumor behavior, therapy resistance, and disease progression. His ultimate goal is to identify novel biomarkers and molecular targets for early detection and personalized treatment in pancreatic ductal adenocarcinoma (PDAC).
